Despite strong cash flow and organic growth in most of its key brands, high leverage and mixed valuation ratios lead to a ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...

The allergy treatment market is set to experience robust growth, with an estimated valuation of US$ 20.20 billion in 2022 and ...

The global cryoglobulinemia treatment market is poised for significant growth, with an expected market value of US$ 496 ...

GlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

Today, Cerebras Systems, the pioneer in high performance AI compute, smashed its previous industry record for inference, ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

The global ulcerated necrobiosis lipoidica management market is poised for significant growth, with an anticipated valuation ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

Dr. Ernest Mario, the founding chair of the Duke University Health System Board of Directors and a leader in the ...